Introduction.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 907, doi. 10.1002/cncr.10752
- By:
- Publication type:
- Article
Works matching IS 0008543X AND DT 2002 AND VI 95 AND IP S4
Results: 7
1
2
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 933, doi. 10.1002/cncr.10754
- By:
- Publication type:
- Article
3
Gemcitabine-based therapy in pancreas cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 923, doi. 10.1002/cncr.10756
- By:
- Publication type:
- Article
4
Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 912, doi. 10.1002/cncr.10758
- By:
- Publication type:
- Article
5
New applications of gemcitabine and future directions in the management of pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 941, doi. 10.1002/cncr.10753
- By:
- Publication type:
- Article
6
The pemetrexed/gemcitabine combination in pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 928, doi. 10.1002/cncr.10755
- By:
- Publication type:
- Article
7
Gemcitabine and platinum combinations in pancreatic cancer.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. S4, p. 908, doi. 10.1002/cncr.10757
- By:
- Publication type:
- Article